home what why for who benefits contact

Accelerating the world’s
adoption of digital medicine

Clinical research | Neuroscience | Digital Biomarkers

what IT MEANS

Novel data collection,
clinical state prediction and
treatment optimization

At Cogniant we are supporting researchers, clinicians and biopharma
companies along the value chain of clinical research & drug discovery for
Psychiatric disorders, Alzhemer’s Disease, & Multiple Sclerosis.

why?

Seamless Client Experience

Our platform integrates health providers,
care givers and clients seamlessly. This ensures
care continuity, secure sharing of information and a connected healthcare ecosystem.

50% only of the patients are
treatment compliant

85% of clinical trials face delays

45% clinical trials fail
due to poor design alone

who is it for

benefits

Behaviour Insights

Our client facing app Sallie™, uses a new and ever increasing dataset. This includes data from mobile phone native sensors, call/text patterns and location sensors to establish digital phenotypes for the client. These digital phenotypes are used to screen and predict for additional behavioural disorders, insomnia and chronic pain that potentially would go unnoticed during treatment.

Scalable

Our scalable offering can be tailored to meet the mental healthcare needs of any organization.

Measurable

Demonstrate return on investment, with reporting tools that show an increase in clinical engagement and client satisfaction

Integrated

Easily integrated into care delivery paths and existing technology

request for demo

what IT MEANS

Novel data collection,
clinical state prediction and
treatment optimization

At Cogniant we are supporting researchers, clinicians and biopharma companies along the value chain of clinical research & drug discovery for Psychiatric disorders, Alzhemer’s Disease, & Multiple Sclerosis.

why?

Delivering On Multi-Dimensional Care

Our platform integrates health providers, care givers, patients and sponsors seamlessly. This ensures care continuity and a connected healthcare ecosystem.

1 in 2

patients are not treatment compliant

85%

Of clinical trials face delays

45%

Of clinical trials fail due to poor design alone

who is it for

Biopharma

Clinical trials & drug discovery

Enriched data to support efficacy and effectiveness clinical studies, enhanced patients selection criteria for clinical trials, cohort studies and evidence generation for multiple drug modalities.

Care providers and carers

Care in the community

Engaging patients in the community, improving real life outcomes by detecting relapses early adjusting patient treatment and driving cost effective care.

Researchers

evaluate treatment efficacy

Cogniant is scientifically proven and is actively looking to expand applications of it’s platform to solve neurological research challenges. We are collaborating with leading researchers and are eager to learn more about what problems you are solving. Get in touch.

benefits

Behaviour Analytics

Our client facing app, Sallie™, uses new and an ever increasing dataset, which includes data from mobile phone native sensors, call/text patterns and location sensors to establish digital phenotypes for the client. These digital phenotypes are used to not only screen but predict for additional behavioural disorders, insomnia and chronic pain which might go unnoticed during physical treatment.

Scalable

Our scalable offering can be tailored to meet the mental healthcare needs of any organization.

Measurable

Demonstrate return on investment, with reporting tools that show an increase in clinical engagement and client satisfaction

Integrated

Easily integrated into care delivery paths and existing technology

request for demo

+65 92969324

info@cogniant.co